$6.63 -0.07 (-1.04%)
11/27/2009 1:00 PM

PDL BioPharma, Inc. (PDLI)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.

Featured Broker Partners